100
Participants
Start Date
May 31, 2007
Primary Completion Date
June 30, 2016
Study Completion Date
May 20, 2022
125-Iodine
Brachytherapy to the prostate via 125-iodine (I-125) seeds with a planned dose of 140 Gy
103-palladium
Brachytherapy to the prostate via 103-palladium (Pd-103) seeds with a planned dose of 120 Gy
Winship Cancer Institute of Emory University, Atlanta
Flower Hospital Cancer Center, Sylvania
Robinson Radiation Oncology, Ravenna
McDowell Cancer Center at Akron General Medical Center, Akron
Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center, Milwaukee
West Allis Memorial Hospital, West Allis
Cancer Institute at St. John's Hospital, Springfield
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis
Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters, City of Saint Peters
University of Colorado Cancer Center at UC Health Sciences Center, Aurora
Arizona Oncology Services Foundation, Phoenix
California Cancer Center - Woodward Park Office, Fresno
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
Cross Cancer Institute at University of Alberta, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
Odette Cancer Centre at Sunnybrook, Toronto
Princess Margaret Hospital, Toronto
Collaborators (1)
National Cancer Institute (NCI)
NIH
NRG Oncology
OTHER
Radiation Therapy Oncology Group
NETWORK